| Benjamin Isaac Mwanika, DO | |
|
2509 Pleasant Run Dr, Harrisonburg, VA 22801-8720 | |
| (540) 689-5500 | |
| (540) 757-7574 |
| Full Name | Benjamin Isaac Mwanika |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 15 Years |
| Location | 2509 Pleasant Run Dr, Harrisonburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457595258 | NPI | - | NPPES |
| 1457595258 | Medicaid | VA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rmh Medical Group Llc | 7618270729 | 208 |
| Kelsey-seybold Medical Group, Pllc | 9739093527 | 610 |
News Archive
Internal medicine residents had low scores in a test of biostatistics knowledge, and about three-fourths of the residents surveyed indicated they have low confidence in understanding the statistics they encounter in medical literature, according to an article in the September 5 issue of JAMA, a theme issue on medical education.
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
While antiretroviral therapies have significantly improved and extended the lives of many HIV patients, another insidious and little discussed threat looms for aging sufferers - HIV-associated neurocognitive disorders (HAND). The disorders, which strike more often in HIV patients over age 50, can result in cognitive impairment, mild to severe, making everyday tasks a challenge.
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.
› Verified 6 days ago
| Entity Name | Rmh Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669844908 PECOS PAC ID: 7618270729 Enrollment ID: O20160125000666 |
News Archive
Internal medicine residents had low scores in a test of biostatistics knowledge, and about three-fourths of the residents surveyed indicated they have low confidence in understanding the statistics they encounter in medical literature, according to an article in the September 5 issue of JAMA, a theme issue on medical education.
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
While antiretroviral therapies have significantly improved and extended the lives of many HIV patients, another insidious and little discussed threat looms for aging sufferers - HIV-associated neurocognitive disorders (HAND). The disorders, which strike more often in HIV patients over age 50, can result in cognitive impairment, mild to severe, making everyday tasks a challenge.
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Isaac Mwanika, DO 11511 Shadow Creek Pkwy, Pearland, TX 77584-7298 Ph: (713) 442-0000 | Benjamin Isaac Mwanika, DO 2509 Pleasant Run Dr, Harrisonburg, VA 22801-8720 Ph: (540) 689-5500 |
News Archive
Internal medicine residents had low scores in a test of biostatistics knowledge, and about three-fourths of the residents surveyed indicated they have low confidence in understanding the statistics they encounter in medical literature, according to an article in the September 5 issue of JAMA, a theme issue on medical education.
Idera Pharmaceuticals, Inc. presented data on the evaluation of a Toll-like receptor (TLR) antagonist in a preclinical hyperlipidemia model today at the Keystone Symposia conference "Advances in Molecular Mechanisms of Atherosclerosis" being held in Banff, Alberta, Canada. Idera's proprietary TLR antagonists have dual activity for both TLR7 and TLR9, and present a potentially innovative approach for the treatment of certain autoimmune diseases.
While antiretroviral therapies have significantly improved and extended the lives of many HIV patients, another insidious and little discussed threat looms for aging sufferers - HIV-associated neurocognitive disorders (HAND). The disorders, which strike more often in HIV patients over age 50, can result in cognitive impairment, mild to severe, making everyday tasks a challenge.
Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee has recommended with an 8-2 vote that the FDA extend the currently approved use of the LAP-BAND® System, Allergan's gastric band, on the basis of a favorable benefit-risk profile for weight reduction in obese adults who have failed more conservative weight reduction alternatives and have a Body Mass Index (BMI) of at least 35 or a BMI ≥30 and at least one comorbid condition.
› Verified 6 days ago
Wayne F Mcnett, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1661 S Main St, Harrisonburg, VA 22801 Phone: 540-564-7300 Fax: 757-431-7100 | |
John A Witman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1751 Erickson Ave, Harrisonburg, VA 22801 Phone: 540-433-3344 Fax: 540-433-0031 | |
Gilbert C Rice Iii, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1790 E Market St Ste 64b, Harrisonburg, VA 22801 Phone: 540-564-5666 Fax: 757-579-8594 | |
Dr. James D Evans, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3322 Emmaus Rd, Harrisonburg, VA 22801 Phone: 540-433-2431 Fax: 540-433-9825 | |
Rebecca Botticelli, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1992 Medical Ave, Harrisonburg, VA 22801 Phone: 540-437-1296 Fax: 540-437-1298 | |
Jeffrey A Ashby, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1831 Reservoir St, Harrisonburg, VA 22801 Phone: 540-433-9151 Fax: 540-433-0547 | |
Dr. Gregory C Jesteadt Ix, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1831 Reservoir St, Harrisonburg, VA 22801 Phone: 540-433-9151 |